Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers The aim of the present study was to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results